Baxalta is developing, manufacturing and commercializing therapies for orphan diseases.
Business Model:
Revenue: $8.3B
Employees: 10,001-999,999
Address: 1 Baxter Pkwy
City: Deerfield
State: IL
Zip: 60015
Country: US
Baxalta is developing, manufacturing and commercializing therapies for orphan diseases.
Contact Phone:
+12249402000
Contact Email:
Listed Exchange:
NYSE
IPO Date:
6/26/2015
Ticker Symbol:
BXLT
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
6/2018 | Precision BioSciences | Series B | 0 |
5/2016 | OncoResponse | Series A | 0 |
6/2018 | Precision BioSciences | Series B | 0 |
5/2016 | OncoResponse | Series A | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|
Announced Date | Name | Price |
---|---|---|
7/2015 | ONCASPAR (pegaspargase) |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|